Ashe Andrew D.
- SEC CIK
- 0001573163
No open-market purchases or sales filed in the past year.
Current role at each company
- VERV Verve Therapeutics, Inc.See Remarksas of Jul 28, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Ashe Andrew D. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 3, 2025 (view filing) | Apr 2 | 1 day | Ashe Andrew D.See Remarks | SSale | −2.68K | $4.15 | −$11.1K | −0.8%348.8K after | 10b5-1 |
| May 15, 2024 (view filing) | May 14 | 1 day | Ashe Andrew D.See Remarks | PPurchase | +76.0K | $6.26 | +$475.8K | +28.5%342.5K after | |
| Dec 6, 2021 (view filing) | Dec 2 | 4 days | Ashe Andrew D.See Remarks | PPurchase | +4.00K | $32.10 | +$128.4K | +2.4%170.7K after |